Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006

Long, GV; Robert, C; Arance, A; Blank, C; Ribas, A; Lorigan, P; Mortier, L; Schachter, J; Middleton, MR; Neyns, B; Sznol, M; Zhou, H; Ebbinghaus, S; Ibrahim, N; Steven, N

EUROPEAN JOURNAL OF CANCER, 2017; 72 ( ): S128